176 related articles for article (PubMed ID: 30060257)
1. Elevating Endogenous Sphingosine-1-Phosphate (S1P) Levels Improves Endothelial Function and Ameliorates Atherosclerosis in Low Density Lipoprotein Receptor-Deficient (LDL-R-/-) Mice.
Feuerborn R; Besser M; Potì F; Burkhardt R; Weißen-Plenz G; Ceglarek U; Simoni M; Proia RL; Freise H; Nofer JR
Thromb Haemost; 2018 Aug; 118(8):1470-1480. PubMed ID: 30060257
[TBL] [Abstract][Full Text] [Related]
2. Deficiency of Endothelial CD40 Induces a Stable Plaque Phenotype and Limits Inflammatory Cell Recruitment to Atherosclerotic Lesions in Mice.
Gissler MC; Scherrer P; Anto-Michel N; Pennig J; Hoppe N; Füner L; Härdtner C; Stachon P; Li X; Mitre LS; Marchini T; Madl J; Wadle C; Hilgendorf I; von Zur Mühlen C; Bode C; Weber C; Lutgens E; Wolf D; Gerdes N; Zirlik A; Willecke F
Thromb Haemost; 2021 Nov; 121(11):1530-1540. PubMed ID: 33618394
[TBL] [Abstract][Full Text] [Related]
3. Deletion of Macrophage Low-Density Lipoprotein Receptor-Related Protein 1 (LRP1) Accelerates Atherosclerosis Regression and Increases C-C Chemokine Receptor Type 7 (CCR7) Expression in Plaque Macrophages.
Mueller PA; Zhu L; Tavori H; Huynh K; Giunzioni I; Stafford JM; Linton MF; Fazio S
Circulation; 2018 Oct; 138(17):1850-1863. PubMed ID: 29794082
[TBL] [Abstract][Full Text] [Related]
4. Hematopoietic sphingosine 1-phosphate lyase deficiency decreases atherosclerotic lesion development in LDL-receptor deficient mice.
Bot M; Van Veldhoven PP; de Jager SC; Johnson J; Nijstad N; Van Santbrink PJ; Westra MM; Van Der Hoeven G; Gijbels MJ; Müller-Tidow C; Varga G; Tietge UJ; Kuiper J; Van Berkel TJ; Nofer JR; Bot I; Biessen EA
PLoS One; 2013; 8(5):e63360. PubMed ID: 23700419
[TBL] [Abstract][Full Text] [Related]
5. Deficiency of Dab2 (Disabled Homolog 2) in Myeloid Cells Exacerbates Inflammation in Liver and Atherosclerotic Plaques in LDLR (Low-Density Lipoprotein Receptor)-Null Mice-Brief Report.
Adamson SE; Polanowska-Grabowska R; Marqueen K; Griffiths R; Angdisen J; Breevoort SR; Schulman IG; Leitinger N
Arterioscler Thromb Vasc Biol; 2018 May; 38(5):1020-1029. PubMed ID: 29599136
[TBL] [Abstract][Full Text] [Related]
6. PAR2 (Protease-Activated Receptor 2) Deficiency Attenuates Atherosclerosis in Mice.
Jones SM; Mann A; Conrad K; Saum K; Hall DE; McKinney LM; Robbins N; Thompson J; Peairs AD; Camerer E; Rayner KJ; Tranter M; Mackman N; Owens AP
Arterioscler Thromb Vasc Biol; 2018 Jun; 38(6):1271-1282. PubMed ID: 29599135
[TBL] [Abstract][Full Text] [Related]
7. Monocyte Adhesion and Plaque Recruitment During Atherosclerosis Development Is Regulated by the Adapter Protein Chat-H/SHEP1.
Herbin O; Regelmann AG; Ramkhelawon B; Weinstein EG; Moore KJ; Alexandropoulos K
Arterioscler Thromb Vasc Biol; 2016 Sep; 36(9):1791-801. PubMed ID: 27417580
[TBL] [Abstract][Full Text] [Related]
8. Sphingosine-1-phosphate receptor 3 regulates the transendothelial transport of high-density lipoproteins and low-density lipoproteins in opposite ways.
Velagapudi S; Wang D; Poti F; Feuerborn R; Robert J; Schlumpf E; Yalcinkaya M; Panteloglou G; Potapenko A; Simoni M; Rohrer L; Nofer JR; von Eckardstein A
Cardiovasc Res; 2024 Apr; 120(5):476-489. PubMed ID: 38109696
[TBL] [Abstract][Full Text] [Related]
9. HDL-bound sphingosine 1-phosphate acts as a biased agonist for the endothelial cell receptor S1P1 to limit vascular inflammation.
Galvani S; Sanson M; Blaho VA; Swendeman SL; Obinata H; Conger H; Dahlbäck B; Kono M; Proia RL; Smith JD; Hla T
Sci Signal; 2015 Aug; 8(389):ra79. PubMed ID: 26268607
[TBL] [Abstract][Full Text] [Related]
10. Apolipoprotein M and Sphingosine-1-Phosphate Receptor 1 Promote the Transendothelial Transport of High-Density Lipoprotein.
Velagapudi S; Rohrer L; Poti F; Feuerborn R; Perisa D; Wang D; Panteloglou G; Potapenko A; Yalcinkaya M; Hülsmeier AJ; Hesse B; Lukasz A; Liu M; Parks JS; Christoffersen C; Stoffel M; Simoni M; Nofer JR; von Eckardstein A
Arterioscler Thromb Vasc Biol; 2021 Oct; 41(10):e468-e479. PubMed ID: 34407633
[TBL] [Abstract][Full Text] [Related]
11. Deficiency of inactive rhomboid protein 2 (iRhom2) attenuates diet-induced hyperlipidaemia and early atherogenesis.
Hannemann C; Schecker JH; Brettschneider A; Grune J; Rösener N; Weller A; Stangl V; Fisher EA; Stangl K; Ludwig A; Hewing B
Cardiovasc Res; 2022 Jan; 118(1):156-168. PubMed ID: 33576385
[TBL] [Abstract][Full Text] [Related]
12. Endothelial Rap1 (Ras-Association Proximate 1) Restricts Inflammatory Signaling to Protect From the Progression of Atherosclerosis.
Singh B; Kosuru R; Lakshmikanthan S; Sorci-Thomas MG; Zhang DX; Sparapani R; Vasquez-Vivar J; Chrzanowska M
Arterioscler Thromb Vasc Biol; 2021 Feb; 41(2):638-650. PubMed ID: 33267664
[TBL] [Abstract][Full Text] [Related]
13. Hematopoietic α7 nicotinic acetylcholine receptor deficiency increases inflammation and platelet activation status, but does not aggravate atherosclerosis.
Kooijman S; Meurs I; van der Stoep M; Habets KL; Lammers B; Berbée JF; Havekes LM; van Eck M; Romijn JA; Korporaal SJ; Rensen PC
J Thromb Haemost; 2015 Jan; 13(1):126-35. PubMed ID: 25345495
[TBL] [Abstract][Full Text] [Related]
14. Angiopoietin-2 blocking antibodies reduce early atherosclerotic plaque development in mice.
Theelen TL; Lappalainen JP; Sluimer JC; Gurzeler E; Cleutjens JP; Gijbels MJ; Biessen EA; Daemen MJ; Alitalo K; Ylä-Herttuala S
Atherosclerosis; 2015 Aug; 241(2):297-304. PubMed ID: 26062989
[TBL] [Abstract][Full Text] [Related]
15. Blockade of Tim-1 and Tim-4 Enhances Atherosclerosis in Low-Density Lipoprotein Receptor-Deficient Mice.
Foks AC; Engelbertsen D; Kuperwaser F; Alberts-Grill N; Gonen A; Witztum JL; Lederer J; Jarolim P; DeKruyff RH; Freeman GJ; Lichtman AH
Arterioscler Thromb Vasc Biol; 2016 Mar; 36(3):456-65. PubMed ID: 26821944
[TBL] [Abstract][Full Text] [Related]
16. SHP2 inhibitor PHPS1 protects against atherosclerosis by inhibiting smooth muscle cell proliferation.
Chen J; Cao Z; Guan J
BMC Cardiovasc Disord; 2018 Apr; 18(1):72. PubMed ID: 29703160
[TBL] [Abstract][Full Text] [Related]
17. Mechanism of sphingosine 1-phosphate clearance from blood.
Kharel Y; Huang T; Salamon A; Harris TE; Santos WL; Lynch KR
Biochem J; 2020 Mar; 477(5):925-935. PubMed ID: 32065229
[TBL] [Abstract][Full Text] [Related]
18. Metformin directly suppresses atherosclerosis in normoglycaemic mice via haematopoietic adenosine monophosphate-activated protein kinase.
Seneviratne A; Cave L; Hyde G; Moestrup SK; Carling D; Mason JC; Haskard DO; Boyle JJ
Cardiovasc Res; 2021 Apr; 117(5):1295-1308. PubMed ID: 32667970
[TBL] [Abstract][Full Text] [Related]
19. Resident Memory T Cells in the Atherosclerotic Lesion Associate With Reduced Macrophage Content and Increased Lesion Stability.
de Jong MJM; Depuydt MAC; Schaftenaar FH; Liu K; Maters D; Wezel A; Smeets HJ; Kuiper J; Bot I; van Gisbergen K; Slütter B
Arterioscler Thromb Vasc Biol; 2024 Jun; 44(6):1318-1329. PubMed ID: 38634281
[TBL] [Abstract][Full Text] [Related]
20. The suppressive effect of sphingosine 1-phosphate on monocyte-endothelium adhesion may be mediated by the rearrangement of the endothelial integrins alpha(5)beta(1) and alpha(v)beta(3).
Aoki S; Yatomi Y; Shimosawa T; Yamashita H; Kitayama J; Tsuno NH; Takahashi K; Ozaki Y
J Thromb Haemost; 2007 Jun; 5(6):1292-301. PubMed ID: 17403093
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
